Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Postoperative Nausea and Vomiting
and you are
between 20 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

Female patients aged between 20 and 70 years, ASA physical status I-II, and scheduled for thyroidectomy under general anaesthesia will be enrolled in the study. Patients will be randomized to the preemptive group to receive an antiemetic regime the day before surgery or to the intraoperative group to receive the same antiemetic drugs in the same doses intraoperatively. In the operating room standard monitoring and a standardized anesthetic technique will be implemented in all patients. Nausea, vomiting, retching and PONV (cumulative) will be recorded immediately after extubation and six hourly thereafter for the first 24 hours. Pain scores assessed by VAS (verbal analogue scale) will be recorded at the same time points. Also, if patients received fluids and solid food by mouth.

Provided treatments

  • Other: Antiemetic treatment the day before surgery vs intraoperatively
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023306. The sponsor of the trial is University of Athens and it is looking for 115 volunteers for the current phase.
Official trial title:
Effectiveness of Preemptive Versus Preventive Antiemetic Treatment in Patients Undergoing Thyroidectomy. A Randomized Double Blind Trial.